Immunosuppressants/rituximabVarious toxicities following an off-label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1924卷 / 1期

关键词：

D O I：

10.1007/s40278-022-23604-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：251 / 251

相关论文

共 50 条

[1] Dapsone/immunosuppressants/rituximabVarious toxicities and off-label use: case report
Reactions Weekly, 2021, 1853 (1) : 161 - 161
[2] RituximabVarious toxicities following off-label use: 5 case reports
Reactions Weekly, 2019, 1734 (1) : 437 - 437
[3] RituximabVarious toxicities following an off-label use: 3 case reports
Reactions Weekly, 2018, 1683 (1) : 600 - 600
[4] RituximabVarious toxicities following off-label use: 8 case reports
Reactions Weekly, 2017, 1669 (1) : 234 - 234
[5] RituximabVarious toxicities following off-label use: 2 case reports
Reactions Weekly, 2020, 1834 (1) : 234 - 234
[6] Immunosuppressants/venetoclaxVarious toxicities and off-label use: case report
Reactions Weekly, 2020, 1819 (1) : 151 - 151
[7] CannabidiolVarious toxicities following off-label treatment: case report
Reactions Weekly, 2021, 1860 (1) : 103 - 103
[8] GuselkumabVarious toxicities following off-label treatment: case report
Reactions Weekly, 2022, 1908 (1) : 264 - 264
[9] OsimertinibVarious toxicities following off-label treatment: case report
Reactions Weekly, 2018, 1724 (1) : 285 - 285
[10] RituximabVarious toxicities and off-label use
Reactions Weekly, 2024, 2017 (1) : 442 - 442

← 1 2 3 4 5 →